Point of Care Diagnostics Market by Product (Glucose, Infectious Disease (Hepatitis C, Influenza, Respiratory), Coagulation), Platform (Microfluidics, Immunoassays), Mode (Prescription & OTC), End-User (Hospitals, Home Care)

The global point-of-care diagnostics market is projected to reach USD 46.7 billion by 2024 from USD 28.5 billion in 2019, at a CAGR of 10.4%.

Factors such as the high prevalence of infectious diseases in developing countries, increasing incidence of target conditions, and increasing inclination toward home healthcare across the globe are driving the market for point-of-care diagnostics. However, product recalls, a lack of alignment with test results obtained from laboratories, stringent & time-consuming approval policies, and a reluctance to change existing diagnostic practices are expected to restrain market growth.

The glucose monitoring products segment is expected to command the largest share of the POC diagnostics market in 2019.

Based on product, the point-of-care diagnostics market is segmented into glucose monitoring, infectious disease testing, cardiometabolic monitoring, coagulation monitoring, hematology testing, urinalysis testing, cholesterol testing, drugs-of-abuse testing, tumor/cancer markers, pregnancy & fertility testing, fecal occult testing, and other POC products. The glucose monitoring products segment is expected to command the largest share of the market in 2019. The increasing number of POC glucose monitoring devices, coupled with the growing prevalence of diabetes, is expected to drive the growth of the POC diagnostics market for glucose monitoring products in the coming years.

The microfluidics segment is expected to register the highest growth rate in the POC diagnostics market, by platform, during the forecast period.

On the basis of platform, the point-of-care diagnostics market is segmented into lateral flow assays, dipsticks, microfluidics, molecular diagnostics, and immunoassays. The microfluidics segment is expected to register the highest growth rate during the forecast period. Technological advancements and increasing initiatives by market players for developing novel microfluidics-based POC products are propelling the growth of the microfluidics market.

The Asia Pacific market is expected to register the highest CAGR during the forecast period.

The point-of-care diagnostics market, by region, is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific market is expected to register the highest growth rate during the forecast period, due to the growing initiatives by market players, increasing patient population base, and rising number of partnerships and joint ventures in this region.

Breakdown of supply-side primary interviews:

By Company Type: Tier 1: 25%, Tier 2: 30%, and Tier 3: 45%
By Designation: C-level: 26%, Director-level: 30%, and Others: 44%
By Region: North America: 34%, Europe: 26%, APAC: 23%, and the RoW: 17%

Prominent players of the point-of-care diagnostics market are Abbott (US), Roche (Switzerland), Siemens (Germany), Danaher (US), Becton, Dickinson, and Company (US), Johnson & Johnson (US), Instrumentation Laboratory (US), PTS Diagnostics (US), Quidel (US), Chembio Diagnostic Systems (US), Sekisui Diagnostics (US), Nova Biomedical (US), EKF Diagnostics (UK), AccuBioTech (China), and Trinity Biotech (Ireland).

Research Coverage

This report studies the point-of-care diagnostics market based on product, platform, mode of purchase, end user, and region. The report also studies factors affecting market growth, analyzes opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends. The report forecasts the revenue of the market segments with respect to the five key regions and their respective countries.

Key Benefits of Buying the Report:

From an insights perspective, this research report has focused on various levels of analysis, such as market share analysis of top players and company profiles, which together comprise and discuss basic views on the competitive landscape, emerging segments of the point-of-care diagnostics market, and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, will help firms garner greater market shares.

Frequently Asked Questions about the Global Point-Of-Care Diagnostics Market

What is the estimated value of the Global Point-Of-Care Diagnostics Market?

The Global Point-Of-Care Diagnostics Market was estimated to be valued at $28.5 billion in 2019.

What is the growth rate of the Global Point-Of-Care Diagnostics Market?

The growth rate of the Global Point-Of-Care Diagnostics Market is 10.4%, with an estimated value of $46.7 billion by 2024.

What is the forecasted size of the Global Point-Of-Care Diagnostics Market?

The Global Point-Of-Care Diagnostics Market is estimated to be worth $46.7 billion by 2024.

Who are the key companies in the Global Point-Of-Care Diagnostics Market?

Key companies in the Global Point-Of-Care Diagnostics Market include Abbott Laboratories, Becton, Dickinson, and Company (BD), Chembio Diagnostics, Danaher Corporation, Johnson & Johnson, Roche Diagnostics (A Subsidiary of F. Hoffmann, La Roche Ltd.), Siemens Healthineers Group, EKF Diagnostics and Quidel.

Report Attribute	Details
No. of Pages	219
Published	November 2019
Forecast Period	2019 - 2024
Estimated Market Value ( USD ) in 2019	$ 28.5 billion
Forecasted Market Value ( USD ) by 2024	$ 46.7 billion
Compound Annual Growth Rate	10.4%
Regions Covered	Global
No. of Companies Mentioned	15

1 Introduction

1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology

2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.2 Market Size Estimation
2.2.1 Product-Based Market Estimation
2.2.2 Market Size Estimation: Overall Market
2.2.3 Primary Research Validation
2.3 Market Breakdown and Data Triangulation
2.4 Research Limitations & Assumptions
2.4.1 Limitations
2.4.2 Assumptions

3 Executive Summary

4 Premium Insights

4.1 POC Diagnostics Market Overview
4.2 Geographic Analysis: POC Diagnostics Market
4.3 POC Diagnostics Market, By Product
4.4 POC Diagnostics Market, By Prescription Mode
4.5 Geographic Snapshot of the POC Diagnostics Market

5 Market Overview

5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 High Prevalence of Infectious Diseases in Developing Countries
5.2.1.2 Increasing Incidence of Target Conditions
5.2.1.3 Growing Government Support
5.2.1.4 Shortage of Skilled Laboratory Technicians
5.2.1.5 Rising Number of Clia-Waived POC Tests
5.2.2 Restraints
5.2.2.1 Pricing Pressure Owing to Reimbursement Cuts and Budget Constraints
5.2.2.2 Stringent and Time-Consuming Regulatory Policies
5.2.3 Opportunities
5.2.3.1 Emerging Markets
5.2.3.2 Healthcare Decentralization - Converting Lab Tests to POC Tests
5.2.3.3 Increasing Awareness Through Conferences and Events
5.2.3.4 POC Tests With Multiplexing Capabilities
5.2.4 Challenges
5.2.4.1 Lack of Alignment With Definitive Central Lab Methods
5.2.4.2 Inadequate Knowledge About the Use of POC Devices in Professional Settings
5.2.4.3 Reluctance to Change Existing Diagnostic Practices
5.2.4.4 High Cost of Devices
5.2.4.5 Product Recalls
5.2.5 Emerging Applications of Point-Of-Care Testing
5.2.5.1 Sepsis Biomarkers
5.2.5.2 Stroke Markers
5.2.5.3 Thyroid Testing
5.2.5.4 Dna Testing
5.2.5.5 Endocrine Testing

6 Point-Of-Care Diagnostics Market, By Product

6.1 Introduction
6.2 Glucose Monitoring Products
6.2.1 Glucose Monitoring Products Account for the Largest Share of the POC Diagnostics Market
6.2.2 Strips
6.2.3 Meters
6.2.4 Lancets & Lancing Devices
6.3 Cardiometabolic Monitoring Products
6.3.1 Cardiac Marker Testing Products
6.3.1.1 Rising Government Initiatives for Cvd Research Will Contribute to Market Growth
6.3.2 Blood Gas/Electrolyte Testing Products
6.3.2.1 Technological Advancements in Blood Gas/Electrolytes Products Will Drive the Growth of This Market Segment
6.3.3 Hba1c Testing Products
6.3.3.1 Government Initiatives are Promoting the Regular Use of Hba1c Testing
6.4 Infectious Disease Testing Products
6.4.1 Influenza Testing Products
6.4.1.1 Rising Influenza Prevalence has Driven Demand for Market Products
6.4.2 Hiv Testing Products
6.4.2.1 Rising Prevalence of Hiv to Drive Market Growth
6.4.3 Hepatitis C Testing Products
6.4.3.1 Central and East Asia are Among the Highly Affected Regions With Hepatitis C
6.4.4 Sexually Transmitted Disease Testing Products
6.4.4.1 Privacy and Confidentiality Issues are the Key Factors Leading to the Adoption of POC Std Testing Products
6.4.5 Healthcare-Associated Infection Testing Products
6.4.5.1 Rising Prevalence of Hais is the Key Factor Driving Market Growth
6.4.6 Respiratory Infection Testing Products
6.4.6.1 POCt Products for the Diagnosis of Respiratory Infections Offer Lower Sensitivity as Compared to Other Tests
6.4.7 Tropical Disease Testing Products
6.4.7.1 Increasing Government Funding for the Use of POC in Tropical Disease Testing Will Support Market Growth
6.4.8 Other Infectious Disease Testing Products
6.5 Coagulation Monitoring Products
6.5.1 Pt/Inr Testing Products
6.5.1.1 Pt/Inr is One of the Most Commonly Used Coagulation Monitoring Methods
6.5.2 Act/Aptt Testing Products
6.5.2.1 Rising Number of Patients Undergoing Angioplasty and Dialysis Globally are Driving Demand for Market Products
6.6 Pregnancy & Fertility Testing Products
6.6.1 Pregnancy Testing Products
6.6.1.1 Pregnancy Testing Will Account for A Larger Market Share Owing to the Rising Inclination Toward Home Testing
6.6.2 Fertility Testing Products
6.6.2.1 Increasing Awareness of Fertility Testing to Drive Market Growth
6.7 Tumor/Cancer Marker Testing Products
6.7.1 Increasing Investments for Research Related to POC Cancer Testing are Driving Growth
6.8 Urinalysis Testing Products
6.8.1 Rising Prevalence of Urinary Tract Infections is Driving Market Growth
6.9 Cholesterol Testing Products
6.9.1 Rising Obesity Levels & Cardiovascular Disorder Incidence are the Key Factors Supporting Market Growth
6.1 Hematology Testing Products
6.10.1 Preference for Laboratory-Based Tests Among Users Will Impede Market Growth
6.11 Drugs-Of-Abuse Testing Products
6.11.1 Rising Consumption of Illicit Drugs has Boosted Demand for Testing
6.12 Fecal Occult Testing Products
6.12.1 Lack of Proper Training in the Use of Fecal Occult Testing Hampers Market Adoption
6.13 Other POC Products

7 Point-Of-Care Diagnostics Market, By Platform

7.1 Introduction
7.2 Lateral Flow Assays
7.2.1 Technological Advancements and Increasing Adoption of Lfa are Supporting Market Growth
7.3 Dipsticks
7.3.1 Dipsticks Help in Routine Analysis of Several Medical Conditions
7.4 Microfluidics
7.4.1 Microfluidics is an Emerging Platform in POC Diagnostics
7.5 Molecular Diagnostics
7.5.1 Increasing Initiatives By Market Players for Developing POC Molecular Diagnostic Products to Drive Market Growth
7.6 Immunoassays
7.6.1 Rising Incidence of Cancer and Growing Awareness About Immunoassay Platforms to Support Market Growth

8 Point-Of-Care Diagnostics Market, By Mode of Purchase

8.1 Introduction
8.2 Prescription-Based Products
8.2.1 Growing Prevalence of Lifestyle Diseases and Favorable Reimbursement Have Driven Market Growth
8.3 OTC Products
8.3.1 Rising Focus on Home Care is Expected to Boost Demand for OTC Testing in the Coming Years

9 Point-Of-Care Diagnostics Market, By End User

9.1 Introduction
9.2 Professional Diagnostic Centers
9.2.1 Clinical Laboratories and Outpatient Healthcare & Ambulatory Care Settings
9.2.1.1 Rapid Result Generation and Availability of Immediate Patient Care are the Major Factors Driving the Growth of This End-User Segment
9.3 Hospitals/Critical Care Centers
9.3.1 Hospitals are Among the Largest End Users of POC Diagnostics
9.4 Home Care Settings
9.4.1 Increasing Inclination Towards Home Healthcare is Driving the Growth of This End-User Segment
9.5 Research Laboratories
9.5.1 Development of Highly Specialized POC Tests and the Increasing Adoption of POCt Devices to Support the Growth of This Segment
9.6 Other End Users

10 Point-Of-Care Diagnostics Market, By Region

10.1 Introduction
10.2 North America
10.2.1 US
10.2.1.1 US Dominated the North American Market in 2019
10.2.2 Canada
10.2.2.1 Rising Government Initiatives to Support the Growth of the POC Diagnostics Market in Canada
10.3 Europe
10.3.1 Germany
10.3.1.1 Germany Accounted for the Largest Share of the European Market
10.3.2 France
10.3.2.1 Growing Public-Private Collaborations for Product Development to Drive Market Growth
10.3.3 UK
10.3.3.1 Growing Awareness of the Benefits Offered By POC Diagnostics to Support Market Growth in the UK
10.3.4 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.1.1 Japan Dominates the APAC POC Diagnostics Market
10.4.2 China
10.4.2.1 Rising Investments By Market Players and the Chinese Government to Drive the Growth of the POC Diagnostics Market in China
10.4.3 India
10.4.3.1 High Burden of Chronic Diseases to Support Market Growth
10.4.4 Rest of Asia Pacific
10.5 Rest of the World (RoW)
10.5.1 Latin America
10.5.1.1 Increasing Prevalence of Infectious Diseases to Drive the Adoption of POC Diagnostics
10.5.2 Middle East & Africa
10.5.2.1 Rising Prevalence of Cancer to Support Market Growth in the MEA

11 Competitive Landscape

11.1 Introduction
11.2 Ranking of Players, 2018
11.3 Competitive Scenario
11.3.1 Product Launches, Enhancements, and Approvals
11.3.2 Agreements, Partnerships, and Collaborations
11.3.3 Acquisitions
11.4 Vendor Dive Overview
11.5 Vendor Inclusion Criteria
11.6 Vendor Dive
11.6.1 Visionary Leaders
11.6.2 Innovators
11.6.3 Dynamic Differentiators
11.6.4 Emerging Companies

12 Company Profiles

12.1 Abbott Laboratories
12.2 Becton, Dickinson, and Company (BD)
12.3 Chembio Diagnostics
12.4 Danaher Corporation
12.5 Johnson & Johnson
12.6 Roche Diagnostics (A Subsidiary of F. Hoffmann-La Roche Ltd.)
12.7 Siemens Healthineers Group
12.8 EKF Diagnostics
12.9 Quidel
12.10 Trinity Biotech
12.11 Accubiotech
12.12 Instrumentation Laboratory (A Werfen Company)
12.13 Nova Biomedical
12.14 PTS Diagnostics (A Part of Sinocare Inc.)
12.15 Sekisui Diagnostics

13 Appendix

13.1 Discussion Guide
13.2 Knowledge Store: Subscription Portal
13.3 Author Details

List of Tables (99 Tables)

Table 1 Recent Waivers of Market Products
Table 2 Point-Of-Care Diagnostics Market, By Product, 2017–2024 (USD Million)
Table 3 Market for Glucose Monitoring Products, By Type, 2017–2024 (USD Million)
Table 4 Market for Glucose Monitoring Products, By Region, 2017–2024 (USD Million)
Table 5 Market for Cardiometabolic Monitoring Products, By Type, 2017–2024 (USD Million)
Table 6 Market for Cardiometabolic Monitoring Products, By Region, 2017–2024 (USD Million)
Table 7 Cardiac Marker Testing Products Market, By Region, 2017–2024 (USD Million)
Table 8 Blood Gas/Electrolyte Testing Products Market, By Region, 2017–2024 (USD Million)
Table 9 Hba1c Testing Products Market, By Region, 2017–2024 (USD Million)
Table 10 Market for Infectious Disease Testing Products, By Type, 2017–2024 (USD Million)
Table 11 Market for Infectious Disease Testing Products, By Region, 2017–2024 (USD Million)
Table 12 Market for Influenza Testing Products, By Region, 2017–2024 (USD Million)
Table 13 Hiv Testing Products Market, By Region, 2017–2024 (USD Million)
Table 14 Hepatitis C Testing Products Market, By Region, 2017–2024 (USD Million)
Table 15 Std Testing Products Market, By Region, 2017–2024 (USD Million)
Table 16 Healthcare-Associated Infection Testing Products Market, By Region, 2017–2024 (USD Million)
Table 17 Respiratory Infection Testing Products Market, By Region, 2017–2024 (USD Million)
Table 18 Tropical Disease Testing Products Market, By Region, 2017–2024 (USD Million)
Table 19 Other Infectious Disease Testing Products Market, By Region, 2017–2024 (USD Million)
Table 20 Market for Coagulation Monitoring Products, By Type, 2017–2024 (USD Million)
Table 21 Market for Coagulation Testing Products, By Region, 2017–2024 (USD Million)
Table 22 Pt/Inr Testing Products Market, By Region, 2017–2024 (USD Million)
Table 23 Act/Aptt Testing Products Market, By Region, 2017–2024 (USD Million)
Table 24 Market for Pregnancy & Fertility Testing Products, By Type, 2017–2024 (USD Million)
Table 25 Market for Pregnancy & Fertility Testing Products, By Region, 2017–2024 (USD Million)
Table 26 Pregnancy Testing Products Market, By Region, 2017–2024 (USD Million)
Table 27 Fertility Testing Products Market, By Region, 2017–2024 (USD Million)
Table 28 Market for Tumor/Cancer Marker Testing Products, By Region, 2017–2024 (USD Million)
Table 29 Market for Urinalysis Testing Products, By Region, 2017–2024 (USD Million)
Table 30 Market for Cholesterol Testing Products, By Region, 2017–2024 (USD Million)
Table 31 Market for Hematology Testing Products, By Region, 2017–2024 (USD Million)
Table 32 Market for Drugs-Of-Abuse Testing Products, By Region, 2017–2024 (USD Million)
Table 33 Market for Fecal Occult Testing Products, By Region, 2017–2024 (USD Million)
Table 34 Market for Other POC Products, By Region, 2017–2024 (USD Million)
Table 35 POC Diagnostics Market, By Platform, 2017–2024 (USD Million)
Table 36 Point-Of-Care Diagnostics Market, By Mode of Purchase, 2017–2024 (USD Million)
Table 37 Prescription-Based Products Market, By Region, 2017–2024 (USD Million)
Table 38 OTC Products Market, By Region, 2017–2024 (USD Million)
Table 39 Market, By End User, 2017–2024 (USD Million)
Table 40 Market for Professional Diagnostic Centers, By Type, 2017–2024 (USD Million)
Table 41 Market for Professional Diagnostic Centers, By Region, 2017–2024 (USD Million)
Table 42 Point-Of-Care Diagnostics Market for Clinical Laboratories and Outpatient Healthcare & Ambulatory Care Settings, By Region, 2017–2024 (USD Million)
Table 43 Market for Hospitals/Critical Care Centers, By Region, 2017–2024 (USD Million)
Table 44 Market for Home Care Settings, By Region, 2017–2024 (USD Million)
Table 45 Market for Research Laboratories, By Region, 2017–2024 (USD Million)
Table 46 Market for Other End Users, By Region, 2017–2024 (USD Million)
Table 47 Market, By Region, 2017–2024 (USD Million)
Table 48 North America: Market, By Country, 2017–2024 (USD Million)
Table 49 North America: Point-Of-Care Diagnostics Market, By Product, 2017–2024 (USD Million)
Table 50 North America: Market, By Mode of Purchase, 2017–2024 (USD Million)
Table 51 North America: Point-Of-Care Diagnostics Market, By End User, 2017–2024 (USD Million)
Table 52 US: Market, By Product, 2017–2024 (USD Million)
Table 53 US: Market, By Mode of Purchase, 2017–2024 (USD Million)
Table 54 US: Market, By End User, 2017–2024 (USD Million)
Table 55 Canada: Market, By Product, 2017–2024 (USD Million)
Table 56 Canada: Point-Of-Care Diagnostics Market, By Mode of Purchase, 2017–2024 (USD Million)
Table 57 Canada: Market, By End User, 2017–2024 (USD Million)
Table 58 Europe: Market, By Country, 2017–2024 (USD Million)
Table 59 Europe: Market, By Product, 2017–2024 (USD Million)
Table 60 Europe: Market, By Mode of Purchase, 2017–2024 (USD Million)
Table 61 Europe: Market, By End User, 2017–2024 (USD Million)
Table 62 Germany: Market, By Product, 2017–2024 (USD Million)
Table 63 Germany: Market, By Mode of Purchase, 2017–2024 (USD Million)
Table 64 Germany: Market, By End User, 2017–2024 (USD Million)
Table 65 France: Market, By Product, 2017–2024 (USD Million)
Table 66 France: Market, By Mode of Purchase, 2017–2024 (USD Million)
Table 67 France: Point-Of-Care Diagnostics Market, By End User, 2017–2024 (USD Million)
Table 68 UK: Market, By Product, 2017–2024 (USD Million)
Table 69 UK: Market, By Mode of Purchase, 2017–2024 (USD Million)
Table 70 UK: Market, By End User, 2017–2024 (USD Million)
Table 71 Roe: Market, By Product, 2017–2024 (USD Million)
Table 72 Roe: Market, By Mode of Purchase, 2017–2024 (USD Million)
Table 73 Roe: Point-Of-Care Diagnostics Market, By End User, 2017–2024 (USD Million)
Table 74 APAC: Market, By Country, 2017–2024 (USD Million)
Table 75 APAC: Market, By Product, 2017–2024 (USD Million)
Table 76 APAC: Market, By Mode of Purchase, 2017–2024 (USD Million)
Table 77 APAC: Market, By End User, 2017–2024 (USD Million)
Table 78 Japan: Market, By Product, 2017–2024 (USD Million)
Table 79 Japan: Market, By Mode of Purchase, 2017–2024 (USD Million)
Table 80 Japan: Market, By End User, 2017–2024 (USD Million)
Table 81 China: Market, By Product, 2017–2024 (USD Million)
Table 82 China: Point-Of-Care Diagnostics Market, By Mode of Purchase, 2017–2024 (USD Million)
Table 83 China: Market, By End User, 2017–2024 (USD Million)
Table 84 India: Market, By Product, 2017–2024 (USD Million)
Table 85 India: Market, By Mode of Purchase, 2017-2024 (USD Million)
Table 86 India: Market, By End User, 2017–2024 (USD Million)
Table 87 RoAPAC: Market, By Product, 2017–2024 (USD Million)
Table 88 RoAPAC: Market, By Mode of Purchase, 2017–2024 (USD Million)
Table 89 RoAPAC: Point-Of-Care Diagnostics Market, By End User, 2017–2024 (USD Million)
Table 90 RoW: Market, By Region, 2017–2024 (USD Million)
Table 91 RoW: Market, By Product, 2017–2024 (USD Million)
Table 92 RoW: Market, By Mode of Purchase, 2017–2024 (USD Million)
Table 93 RoW: Market, By End User, 2017–2024 (USD Million)
Table 94 Latin America: Market, By Product, 2017–2024 (USD Million)
Table 95 Latin America: Market, By Mode of Purchase, 2019–2024 (USD Million)
Table 96 Latin America: Market, By End User, 2017–2024 (USD Million)
Table 97 Middle East & Africa: Market, By Product, 2017–2024 (USD Million)
Table 98 Middle East & Africa: Market, By Mode of Purchase, 2017–2024 (USD Million)
Table 99 Middle East & Africa: Market, By End User, 2017–2024 (USD Million)

List of Figures (31 Figures)

Figure 1 Research Methodology Steps
Figure 2 Research Design
Figure 3 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 4 Research Methodology: Hypothesis Building
Figure 5 Data Triangulation
Figure 6 Point-Of-Care Diagnostics Market, By Product, 2019 vs. 2024 (USD Million)
Figure 7 Market, By Mode of Purchase, 2019 vs. 2024
Figure 8 Market Share, By Platform, 2019 vs. 2024
Figure 9 Market, By End User, 2019 vs. 2024
Figure 10 Market, By Region
Figure 11 Growing Government Support is Driving the Adoption of POC Devices Across the Globe
Figure 12 Professional Diagnostic Centers Segment Dominated the POC Diagnostics Market in 2018
Figure 13 Glucose Monitoring Kits Segment to Dominate the POC Diagnostics Market During the Forecast Period
Figure 14 Prescription-Based Testing Kits to Dominate the POC Diagnostics Market During the Forecast Period
Figure 15 North America to Register the Highest Cagr During the Forecast Period
Figure 16 POC Diagnostics Market: Drivers, Restraints, Opportunities, and Challenges
Figure 17 Point-Of-Care Diagnostics Market: Growth Forecast, By Region (2019–2024)
Figure 18 North America: Market Snapshot
Figure 19 APAC: Market Snapshot
Figure 20 Roche Diagnostics Held the Leading Position in the Market in 2018
Figure 21 Vendor Dive: Evaluation Overview
Figure 22 Abbott Laboratories: Company Snapshot
Figure 23 BD: Company Snapshot
Figure 24 Chembio Diagnostics: Company Snapshot
Figure 25 Danaher Corporation: Company Snapshot
Figure 26 Johnson & Johnson: Company Snapshot
Figure 27 Roche Diagnostics: Company Snapshot
Figure 28 Siemens Healthineers Group: Company Snapshot
Figure 29 EKF Diagnostics: Company Snapshot
Figure 30 Quidel: Company Snapshot
Figure 31 Trinity Biotech: Company Snapshot

Samples

LOADING...

Executive Summary

Companies Mentioned

Abbott Laboratories
Becton, Dickinson, and Company (BD)
Chembio Diagnostics
Danaher Corporation
Johnson & Johnson
Roche Diagnostics (A Subsidiary of F. Hoffmann-La Roche Ltd.)
Siemens Healthineers Group
EKF Diagnostics
Quidel
Trinity Biotech
Accubiotech
Instrumentation Laboratory (A Werfen Company)
Nova Biomedical
PTS Diagnostics (A Part of Sinocare Inc.)
Sekisui Diagnostics

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€4725EUR$4,950USD£4,054GBP
1 - 5 USER LICENSE PDF	The product is a PDF.	This is a 1-5 user license, allowing up to five users have access to the product.	€6347EUR$6,650USD£5,446GBP
SITE LICENSE PDF	The product is a PDF.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€7779EUR$8,150USD£6,675GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€9544EUR$10,000USD£8,190GBP

Point of Care Diagnostics Market by Product (Glucose, Infectious Disease (Hepatitis C, Influenza, Respiratory), Coagulation), Platform (Microfluidics, Immunoassays), Mode (Prescription & OTC), End-User (Hospitals, Home Care) - Global Forecast to 2024

What is the estimated value of the Global Point-Of-Care Diagnostics Market?

What is the growth rate of the Global Point-Of-Care Diagnostics Market?

What is the forecasted size of the Global Point-Of-Care Diagnostics Market?

Who are the key companies in the Global Point-Of-Care Diagnostics Market?

Table of Contents

Samples

Executive Summary

Companies Mentioned

What is the estimated value of the Global Point-Of-Care Diagnostics Market?

What is the growth rate of the Global Point-Of-Care Diagnostics Market?

What is the forecasted size of the Global Point-Of-Care Diagnostics Market?

Who are the key companies in the Global Point-Of-Care Diagnostics Market?

Table of Contents

Samples

Executive Summary

Companies Mentioned

Related Topics

Related Reports

Immunoassay Markets. Strategies and Trends. Forecasts by Application, Technology, Product, User and by Country. With Executive Guides, Customized Forecasting and Analysis. 2023 to 2027

Global Point of Care Diagnostics Market with Focus on Asia-Pacific: Insights & Forecast with Potential Impact of COVID-19 (2023-2027)

Lateral Flow Assays Market - Global Outlook & Forecast 2023-2028

Point of Care/Rapid Diagnostics Market by Product (Glucose, HIV, Hepatitis C, Pregnancy), Platform (Microfluidics, Dipstick, Immunoassay), Purchase (OTC, Prescription), Sample(Blood, Urine), User (Pharmacy, Hospital, Homecare) - Global Forecast to 2027

In-Vitro Diagnostics Market by Offering (Kits, Software), Technology (Immunoassay, Molecular Diagnostics [PCR, NGS, Microarray], Rapid Tests, Biochemistry), Application (Infectious Diseases, Oncology), Diagnostic Approach (Lab, POC) - Global Forecast to 2030